1. Introduction {#sec1}
===============

Carcinoid tumor is a neuroendocrine tumor that can arise from various body sites including gastrointestinal tract and bronchopulmonary system \[[@bib1], [@bib2], [@bib3]\]. Carcinoid tumors of the lung constitute 10--25% of total carcinoid tumors \[[@bib1], [@bib2], [@bib3]\] and 0.5--2% of all lung tumors \[[@bib4],[@bib5]\]^.^ Hemoptysis is one of the most common presenting symptoms in carcinoid tumor \[[@bib5], [@bib6], [@bib7]\] which most commonly arises in the proximal airways and can be hypervascular. We describe a case of 34-year old previously healthy male who presented with hemoptysis and underwent bronchoscopy for inspection. However, he developed massive hemorrhage leading to intubation and abortion of the procedure with subsequent angiographic embolization that was successful in controlling the bleeding. This case sheds light on the importance of careful planning for bronchoscopy when carcinoid tumor is suspected.

2. Case presentation {#sec2}
====================

A 34-year old previously healthy Caucasian male presented with hemoptysis of 3-day duration. The patient quantified his hemoptysis as an ounce of clotted blood twice daily. He denied any associated cough, shortness of breath or wheezing. He stated that he had a brief episode of hemoptysis five months prior to presentation, for which he was treated as pneumonia by his primary care physician with subsequent resolution of hemoptysis. A thorough review of systems was done and was only positive for fatigue over the 4--5 days prior to presentation. He denied fevers, chills, weight loss, night sweats, lightheadedness, chest pain, nausea, vomiting, and diarrhea. There was no history of recent travel or trauma. Past medical and surgical histories were negative. Family history was positive for cervical cancer in mother and negative for lung disease. He smoked half a pack a day for 14 years, used marijuana daily, reported occasional alcohol intake, but no other illicit drugs.

On examination, the patient did not appear to be ill or in distress. Initial vital signs were: temperature 36.8 °C, blood pressure 109/64 mmHg, heart rate 51 beats/min, respiratory rate 18 breaths/min, and pulse oximetry 97% on room air. Examination of the neck was negative for lymphadenopathy and thyroid enlargement. Lungs were clear with good air entry and breath sounds bilaterally, no wheezing or crackles. Cardiovascular examination revealed regular rate and rhythm without murmurs. The abdomen was soft, non-tender with normal bowel sounds and no hepatosplenomegaly. Extremities were warm without clubbing, cyanosis or edema. Neurological exam was intact.

Laboratory tests were normal including complete blood count, renal function panel, liver enzymes and coagulation profile. Chest radiograph showed right middle lobe opacity ([Fig. 1](#fig1){ref-type="fig"}). Unenhanced computed tomography (CT) of the chest showed endobronchial mass of the bronchus intermedius containing dystrophic calcifications ([Fig. 2](#fig2){ref-type="fig"}). Patient underwent inspection bronchoscopy which revealed bright red blood originating from large endobronchial tumor obstructing the bronchus intermedius ([Fig. 3](#fig3){ref-type="fig"}). Due to massive hemorrhage, the patient was intubated for airway protection, an endobronchial blocker was placed into the right mainstem bronchus, and bronchoscopy was aborted. Estimated blood loss was 200 ml and bleeding was persistent the entire procedure time (more than one hour) even after the instillation of 14 ml of Epinephrine (1:10,000) via bronchoscope. CT chest angiography showed large mass extending from the region of the right mainstem bronchus. The mass appeared to be supplied by a bronchial artery at the level of T4 ([Fig. 4](#fig4){ref-type="fig"}). Right bronchial arteriogram showed a right bronchial artery perfusion to a hypervascular right hilar mass corresponding with the hemorrhagic mass shown on CT chest and bronchoscopy ([Fig. 5](#fig5){ref-type="fig"}). The right bronchial artery supplying the mass was subsequently embolized. The patient\'s hemoptysis improved and he went for general anesthesia bronchoscopy with endobronchial biopsies. He later underwent posterolateral thoracotomy and bi-lobectomy (right middle and lower lobes) for mass removal.Fig. 1Posteroanterior radiograph of the chest showing a mass like opacity in the medial aspect of the right lower lung (arrow), silhouetting the right heart border, likely located in the medial segment of the right middle lobe.Fig. 1Fig. 2Noncontract computed tomography of the chest at the level of bronchus intermedius, showing a mass (circle) with large dystrophic calcification (black arrow) and an area of cystic appearing lesion more anteriorly (blue arrow), which is likely a bronchocele associated with the mass.Fig. 2Fig. 3Right mainstem bronchus-endobronchial large, smooth, friable mass occluding bronchus intermedius.Fig. 3Fig. 4Reconstructed contrast enhanced CT of the chest in oblique coronal Maximal Intensity Projection (MIP) at the area of the tumor, showing the mass in the right bronchus intermedius with dystrophic calcification (circle). The bronchial artery supplying the mass is visible (blue arrow). Black arrow points to bronchial blocker placed for massive hemorrhage and displaced into the left bronchial tree.Fig. 4Fig. 5Digital subtraction catheter angiographic image at the site of the tumor demonstrates the bronchial artery supplying the mass (arrow). Faint blushing of contrast is seen at the site of the tumor, in keeping with hypervascular nature of the tumor.Fig. 5

Macroscopic examination of the right middle and lower lobes revealed a tumor protruding into the mainstem bronchus, abutting the bronchial margin. On cross section, the mainstem bronchus was expanded by a poorly demarcated, irregular, yellow-white, firm mass that measured 3.5 cm in greatest dimension ([Fig. 6](#fig6){ref-type="fig"}). Microscopic evaluation revealed a distinct population of small, polygonal neoplastic cells with granular, pale eosinophilic cytoplasm and open, "salt and pepper" chromatin within rounded nuclei. Mitoses were infrequent ([Fig. 7](#fig7){ref-type="fig"}) and there were regions of squamous and osseous metaplasia observed within the mass. The histopathological findings were consistent with typical carcinoid tumor.Fig. 6Gross photo of right middle lobe and right lower lobe with poorly demarcated, firm yellow-white mass (black circle) expanding the right mainstem bronchus (black arrow).Fig. 6Fig. 7Hematoxylin and Eosin; Typical Carcinoid Tumor (200×). Small, polygonal neoplastic cells with granular, pale eosinophilic cytoplasm. Nuclei are round with open, "salt and pepper" chromatin. Mitotic figures are absent. Inset (400×); Finely stippled, "salt and pepper" chromatin (black arrow) without nuclear atypia or mitotic activity.Fig. 7

3. Discussion {#sec3}
=============

This case depicts a young previously healthy male presenting with hemoptysis without any other symptoms. Unenhanced CT of the chest showed endobronchial mass of the bronchus intermedius with no lymph node enlargement. While the differential diagnosis include hamartomas, benign mesenchymal tumors and other lung cancers, the presentation is consistent with carcinoid tumor. Hemoptysis is one of the most common presenting symptoms in carcinoid tumors \[[@bib5], [@bib6], [@bib7]\] which often arise in proximal airways and are frequently hypervascular. Other presenting symptoms include cough, dyspnea, chest pain, and less commonly diarrhea and sweating/flushing \[[@bib5],[@bib6]\]. On the other hand, 39% of the patients with carcinoid tumor were asymptomatic in one series of 126 patients \[[@bib5]\]. Carcinoid tumors tend to occur in younger patients and can lead to pneumonia due to bronchial obstruction \[[@bib6],[@bib7]\], a possible explanation for the patient\'s history of community acquired pneumonia five months prior to presentation.

Radiographically, pulmonary carcinoids often appear as well-defined, round or ovoid tumors that are usually located near the hila or the central airways \[[@bib1]\], which what this patient\'s imaging showed, a mass in the bronchus intermedius. They present as central tumors in approximately 70% of the cases \[[@bib8]\] and less commonly as peripheral lung nodules or masses which are more likely to be detected incidentally \[[@bib9]\]. Pulmonary carcinoids have been described as containing calcifications in approximately 30% of cases \[[@bib7]\]. In this report, CT chest showed large dystrophic calcifications in the carcinoid tumor ([Fig. 2](#fig2){ref-type="fig"}). Calcification pattern is not a specific characteristic for the diagnosis of pulmonary carcinoids. Irregular, central, and eccentric calcification patterns have all been reported. Central tumors may more frequently contain calcifications compared to peripheral tumors \[[@bib10]\].

Inspection bronchoscopy and biopsy of bronchial carcinoid tumor is considered safe \[[@bib11]\]. However, in one review of carcinoid tumors of the lung, tumor biopsy resulted in moderate to severe hemorrhage in 6 out of 23 cases \[[@bib7]\]. Massive hemorrhage requiring intubation and placement of bronchial blocker occurred in our case without biopsy. This may be due to strong cough during bronchoscopy often seen in young patients leading to worsening bleeding of the carcinoid tumor.

4. Conclusion {#sec4}
=============

Carcinoid tumors should be suspected in younger patients presenting with hemoptysis and lung mass. History of pneumonia or recurrent pneumonitis should alert physicians for possible bronchial obstruction caused by the tumor. With hemoptysis as a presenting symptom, careful planning maybe warranted for bronchoscopy due to the potential hypervascularity of these tumors and the risk of massive hemorrhage. Pulmonary angiogram in this case demonstrated the bronchial artery supplying the mass and successful embolization resulted in control of bleeding.
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